Reliance Clinical Research Services - About
Reliance Clinical Research Services
(RCRS), a contract research organization (CRO)
and wholly owned subsidiary of Reliance Life Sciences,
has been set up with the vision of providing world-class
clinical research services to pharmaceutical,
biotechnology and medical device companies.
The headquarters of RCRS is located at the Reliance
Life Sciences facilities in Navi Mumbai, India.
RCRS has facilities in Navi Mumbai and Bangalore
in India, and business development offices in
USA and UK.
The service offerings at RCRS include Preclinical
Development, Phase I-IV Clinical Trial Management
and Monitoring, Bioequivalence studies, Pharmacokinetic
& Pharmacodynamic studies, Cardiac Safety
(thorough QTc) studies, Pharmacovigilance, Biometrics,
Regulatory Affairs, Quality Assurance, Diagnostic
Laboratory Services, Bioanalytical services &
Medical Writing (clinical trial documents &
peer-review publications). RCRS has successfully
established a team of highly qualified and experienced
staff including Physicians, PhDs, and multi-disciplinary
GCP trained staff. The services provided by
RCRS are knowledge-driven and based on the understanding
of the pharmacology and molecular basis of disease.
RCRS has also established an comprehensive investigator
database. Further, RCRS is proud of being the
first CRO in India having its Central Pathology
Laboratory accredited by College of American
Pathologists (CAP) within the first two years
of its inception. Its Molecular Diagnostics
Laboratory is also accredited by National Accreditation
Board for Calibration and Testing Laboratories
(NABL) and College of American Pathologists
(CAP).
The RCRS team is able to provide a global reach
to our clients by utilizing its network with
investigators in South East Asia, Eastern Europe
and the Commonwealth of Independent States (CIS)
countries. Our therapeutic experience includes
conduct of studies in over 14 therapeutic domains
namely oncology, endocrinology, dermatology,
hematology, gastroenterology, neurology, cardiovascular,
vaccines, psychiatry, gynecology, infectious
diseases, regenerative disorders, ophthalmology
and nephrology.
Reliance Life Sciences
Reliance Life Sciences, incorporated in the year
2001, is an initiative of the Reliance Group.
Reliance Group is the largest private sector enterprisein
India, participating in businesses in the energy
and materials value chain, with group revenues
of USD 29.7 billion. The flagship company,
Reliance Industries Limited, is a Fortune Global 500 company,
and ranks 103rd amongst the world's Top 200 companies
in terms of revenues.
Reliance Life Sciences is developing business
opportunities in the domains of medical, plant
and industrial biotechnology. From a domain perspective,
these opportunities cover Biopharmaceuticals,
Pharmaceuticals, Clinical Research Services, Regenerative
Medicine, Molecular Medicine, Novel Therapeutics,
BioFuels, Plant Tissue Culture, Plant Metabolic
Engineering and Industrial Biotechnology. From
an integration perspective, these opportunities
encompass Repositories, Research, Process Development,
Pre-clinical Studies, Human Clinical Trials, Commercial-scale
Manufacture and Marketing, all of which are carried
out in-house. |
